ArticleCancers2022

HER2-Low Status Is Not Accurate in Breast Cancer Core Needle Biopsy Samples: An Analysis of 5610 Consecutive Patients.

Yujie Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.